meRfi®-GM
Exclusive Enteral Nutrition (EEN) & Crohn’s Disease (CD)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Exclusive enteral nutrition (EEN) is a first-line therapy for pediatric Crohn's disease (CD). It generates temporally and individually variable microbiome profiles and induces remission in patients with pediatric Crohn's disease. Medium-chain fatty acids (lauric acid, Decanoic acid, and Octanoic acid) in the EEN are associated with protective changes in the microbiota of CD patients. Lachnospiraceae are also identified as protective features. They are significantly enriched in…
References (Sources)
- Analysis of 61 exclusive enteral nutrition formulas used in the management of active Crohn’s disease - new insights into dietary disease triggers
- Exclusive enteral nutrition in active pediatric Crohn disease: Effects on intestinal microbiota and immune regulation
- Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn’s Disease: Determinants of Higher Adherence and Response
- The Crohn’s Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions
- Treatment of active Crohn’s disease with an ordinary food-based diet that replicates exclusive enteral nutrition
- Treatment of Active Crohn’s Disease With Exclusive Enteral Nutrition Diminishes the Immunostimulatory Potential of Fecal Microbial Products
- Use of Enteral Nutrition for the Control of Intestinal Inflammation in Pediatric Crohn Disease